What is Exagen Inc.'s cash ratio?

Exagen Inc. (XGN) reported cash ratio of 1.7× in Q1 2026.

How has Exagen Inc.'s cash ratio changed year-over-year?

Exagen Inc.'s cash ratio increased by 112.3% year-over-year, from 0.8× to 1.7×.

What is the long-term trend for Exagen Inc.'s cash ratio?

Over 5 years (2020 to 2025), Exagen Inc.'s cash ratio has grown at a -19.0% compound annual growth rate (CAGR), from 6.6× to 2.3×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Exagen Inc. XGN Cash ratio

Cash ratio at other companies

Labcorp HoldingsLH

0.4×+0.2×

Quest DiagnosticsDGX

0.2×0.0×

Vor BiopharmaVOR

10.6×+7.6×

Avalo TherapeuticsAVTX

2.2×-20.1×

CareDxCDNA

1×-0.1×

Bio-Rad LaboratoriesBIO

0.6×-0.5×

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Calculated from Exagen Inc.’s reported figures.

cash and equivalents/total current liabilities=1.7×

Based on the most recent quarter.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s cash ratio?: Exagen Inc. (XGN) reported cash ratio of 1.7× in Q1 2026.
How has Exagen Inc.'s cash ratio changed year-over-year?: Exagen Inc.'s cash ratio increased by 112.3% year-over-year, from 0.8× to 1.7×.
What is the long-term trend for Exagen Inc.'s cash ratio?: Over 5 years (2020 to 2025), Exagen Inc.'s cash ratio has grown at a -19.0% compound annual growth rate (CAGR), from 6.6× to 2.3×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.